Compare DRUG & NKLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRUG | NKLR |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.4M | 623.2M |
| IPO Year | 2020 | 2025 |
| Metric | DRUG | NKLR |
|---|---|---|
| Price | $60.45 | $4.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $129.25 | $15.00 |
| AVG Volume (30 Days) | 76.2K | ★ 247.6K |
| Earning Date | 05-15-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $44.25 | $3.73 |
| 52 Week High | $123.75 | $12.43 |
| Indicator | DRUG | NKLR |
|---|---|---|
| Relative Strength Index (RSI) | 28.03 | 37.08 |
| Support Level | $56.47 | $4.06 |
| Resistance Level | $78.35 | $5.20 |
| Average True Range (ATR) | 2.92 | 0.37 |
| MACD | -1.28 | -0.11 |
| Stochastic Oscillator | 4.75 | 9.15 |
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Terra Innovatum Global NV is a micro modular nuclear solutions company that aims to deliver reliable, low-cost, and zero-carbon power wherever energy demand is present through its first-of-a-kind reactor, SOLO. SOLO is compact yet extremely powerful, with one unit generating 1MWe of power, while designed with the strictest safety characteristics and the ability to run 24/7 without the need to refuel for 15 years. Its modular design aims to achieve maximum energy efficiency while significantly reducing the levelized cost of energy (LCOE). SOLO is built using off-the-shelf components and widely available fuel, low-enriched uranium (LEU), which de-risks its regulatory and commercial pathway.